Skip to content

Sleep Loss and Glucose Metabolism in People With Family History of Type 2 Diabetes.

Sleep, Energy Metabolism and Diabetes Risk.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00721019
Enrollment
11
Registered
2008-07-23
Start date
2008-07-31
Completion date
2012-03-31
Last updated
2013-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance, Sleep, Sleep Deprivation, Type 2 Diabetes

Keywords

short sleep duration, glucose clamp technique, insulin secretion, insulin action, lipid turnover, free fatty acids

Brief summary

The use of sugar and starch-like foods for energy (carbohydrate metabolism) changes when people sleep. However, it is still not known if differences in the amount of nighttime sleep have an effect on the carbohydrate metabolism of people who have a relative with type 2 diabetes (parent, sibling, or grandparent). This study is being done to test the hypothesis that the carbohydrate metabolism of people who have a history of type 2 diabetes in their family will be different after they have slept short hours for 10 days in comparison to when they have slept longer hours for 10 days.

Detailed description

Study participants will complete two 10-day inpatient stays in the sleep laboratory of the University of Chicago Clinical Resource Center scheduled at least 4 weeks apart. Bedtime duration will be set at 5 hours per night during one of these stays and 8.5 hours per night during the other. No daytime naps will be allowed. Study participants will be served regular daily meals including breakfast, lunch, dinner, and a bedtime snack. On weekdays all participants will engage in simulated office work while in the sleep laboratory. During the rest of the time participants will maintain their usual indoor and outdoor activities as much as possible within the limits of the University of Chicago campus. During the last two days of each inpatient stay in the laboratory, participants will undergo two different tests. The first test will determine how much insulin does their body produce in response to an intravenous glucose infusion lasting several hours. The second test will determine how effective is the action of the sugar-processing hormone, insulin, in their body when it is infused intravenously together with glucose over a period of several hours.

Interventions

OTHER5-hour bedtime

10 days with sleep restricted only to a 5-hour bedtime period at night

OTHER8.5-hour bedtimes

10 days with sleep allowed only during a 8.5-hour period at night

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* regular sleep habits * BMI 20 to 27 kg/m2 * at least one parent, sibling or grandparent with type 2 diabetes * no regular exercise habits

Exclusion criteria

* active smoker * night or shift work * have highly variable sleep habits * have a hormonal disorder * have a sleep disorder * have an active medical problem * women only: use of birth control pills * women only: irregular menstrual periods or pregnancy * use of medications/compounds that can disrupt sleep

Design outcomes

Primary

MeasureTime frame
Total body insulin sensitivityat the end of each bedtime intervention

Secondary

MeasureTime frame
First and second phase insulin secretionat the end of each bedtime intervention
Endogenous glucose productionat the end of each bedtime intervention
Glycerol turnover and free fatty acid concentrationsat the end of each bedtime intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026